基于不同放射学亚型的原发性肺粘液腺癌的临床病理特征和生存结果。
Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.
发表日期:2023 Nov 05
作者:
Wei Li, Yingying Yang, Menghang Yang, Nan Song, Ziwei Wan, Qing Lu, Jingyun Shi
来源:
ANNALS OF SURGICAL ONCOLOGY
摘要:
根据高分辨率计算机断层扫描的结果,原发性肺粘液腺癌(LMA)可分为纯实性型、部分实性型和肺炎型。本研究旨在基于大量患者的放射学分类,阐述 LMA 的临床病理学、放射学和预后特征。从 2009 年 11 月至 2016 年 12 月,本研究入组了 294 例切除的 LMA,分为纯实性(纯实性)、 n = 169)、部分实体型 (n = 87) 和肺炎型 (n = 38)。评估肿瘤的临床病理学和放射学特征,并通过随访评估确定患者预后。通过卡普兰-迈耶曲线计算生存结果,并使用对数秩检验进行比较。通过建立 Cox 比例风险模型来评估临床病理变量(包括放射学表现)的预后影响。LMAs 很少与淋巴结转移 (5.4%)、淋巴管/血管侵犯 (4.4%) 或内脏胸膜侵犯 (5.1%) 相关。 %)。在中位 71 个月的随访期内,62 名患者出现复发,44 名患者死亡。肺炎型 LMA 患者的预后(5 年无复发生存率 [RFS],23.7%;5 年总生存率 [OS],44.7%)比纯实体型患者(RFS,83.2%)较差。 %;OS,100 %)或部分固体型(RFS,93.7 %;OS,100 %)。此外,淋巴结转移、肺气肿和临床T分期是RFS和OS的独立预测因素。孤立型LMA患者预后良好,而肺炎型LMA患者的生存结果较差。此外,肺炎型 LMA 患者更容易通过气道播散而非远处转移发生肺内转移。© 2023。外科肿瘤学会。
Primary lung mucinous adenocarcinomas (LMAs) could be subclassified as the pure-solid, part-solid, and pneumonic types according to the findings of high-resolution computed tomography. This study aimed to expound on the clinicopathologic, radiologic, and prognostic characteristics of LMAs based on radiologic classification within a large set of patients.From November 2009 to December 2016, this study enrolled 294 resected LMAs, which were divided into the pure-solid (n = 169), part-solid (n = 87), and pneumonic (n = 38) types. The clinicopathologic and radiologic characteristics of the tumors were evaluated, and patient prognosis was determined through follow-up evaluation. Survival outcomes were calculated by Kaplan-Meier curves and compared using log-rank tests. The prognostic impact of clinicopathologic variables, including radiologic presentations, were evaluated by establishing a Cox proportional hazards model.The LMAs were infrequently associated with lymph node metastasis (5.4 %), lymphatic/vascular invasion (4.4 %), or visceral pleural invasion (5.1 %). During the median 71-month follow-up period, recurrence was observed in 62 patients and death in 44 patients. The patients with pneumonic-type LMAs had a poorer prognosis (5-year recurrence-free survival [RFS], 23.7 %; 5-year overall survival [OS], 44.7 %) than those with the pure-solid type (RFS, 83.2 %; OS, 100 %) or part-solid type (RFS, 93.7 %; OS, 100 %). Besides, lymph node metastasis, emphysema, and clinical T stage were independent predictors of RFS and OS.Solitary-type LMA patients had excellent prognoses, whereas the survival outcomes for pneumonic-type LMA patients were dismal. Furthermore, pneumonic-type LMA patients were prone to intrapulmonary metastasis by means of aerogenous dissemination rather than distant metastasis.© 2023. Society of Surgical Oncology.